Cleared Traditional

K971582 - NIPRO CORELESS NEEDLE/CORELESS NEEDLE SET

K971582 is an FDA 510(k) clearance for NIPRO CORELESS NEEDLE/CORELESS NEEDLE SET, manufactured by Nipro Medical Corp.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 236-day FDA review.

K971582 · Nipro Medical Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1997
Decision
236d
Days
Class 2
Risk

K971582 is an FDA 510(k) clearance for the NIPRO CORELESS NEEDLE/CORELESS NEEDLE SET. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by Nipro Medical Corp. (Lexington, US). The FDA issued a Cleared decision on December 22, 1997 after a review of 236 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Nipro Medical Corp. devices

FDA 510(k) Submission Details - K971582

510(k) Number K971582 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 30, 1997
Decision Date December 22, 1997
Days to Decision 236 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
107d slower than avg
Panel avg: 129d · This submission: 236d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 242
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K971582.
PORT-A-CATH- II DUAL-LUMEN LOW PROFILE SYSTEM, PORT-A-CATH II DUAL LUMEN LOW PROFILE SYSTEM WITH INTRODUCER SET, PORT-A
K974471 · Sims Deltec, Inc. · Jan 1998
HUBERLOC
K973497 · Medcare Medical Group, Inc. · Jan 1998
PORT-A-CATH LOW-PROFILE IMPLANTABLE ACCESS SYSTEMS
K973862 · Sims Deltec, Inc. · Dec 1997
VITAL-PORT INFUSION PAL
K971140 · Med Institute, Inc. · Nov 1997
TARGET VITAL-PORT VASCULAR ACCESS SYSTEM
K970442 · Med Institute, Inc. · Apr 1997
NON-PVC FLUID PATH PORT ACCESS INFUSION SET WITH SLIT SEPTUM INJECTION SITE
K964117 · Kawasumi Laboratories Co., Ltd. · Mar 1997